Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACA vs MLM

Arcosa, Inc. vs Martin Marietta Materials — AI-powered side-by-side comparison
ACA
Arcosa, Inc.
63
Buy
VS
MLM
Martin Marietta Materials
59
Buy
MetricACAMLM
AI Score 63 59
Price $145.30 $533.12
P/E Ratio 14.53× 13.07×
ROE 7.9% 11.3%
Revenue Growth YoY
Gross Margin 23.0% 28.2%
Debt / Equity 0.48× 0.52×
Dividend Yield 0.1% 0.6%
RSI (14) 55.2 44.1
Beta 1.071 1.106
Expected Upside +1.0% +5.0%

AI Committee View

Current Innellis committee reasoning for ACA versus MLM.
ACA leads by 4 points.

ACA scores 63/100 (Buy) versus MLM at 59/100 (Buy).

ACA Committee View
75% agreement
4 analysts

Supporting evidence favours the bullish case. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Price structure making higher highs and higher lows — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
MLM Committee View
60% agreement
5 analysts

The primary driver is p/e of 13.3 is inexpensive for the broad market. The main limiting factor is price structure making lower highs and lower lows. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 13.3 is inexpensive for the broad market — Value
  • ROE of 23.1% shows genuine earnings power backing the valuation — Value
  • EPS growing 125.7% YoY — Growth
Bear Case
  • Price structure making lower highs and lower lows — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Trend and market structure agree -- coherent bearish picture — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACA Full Analysis MLM Full Analysis